Researchers trying to block enzymes that make ovarian cancer chemo-resistant

January 29, 2014 by Rose Trapnell
Researchers trying to block enzymes that make ovarian cancer chemo-resistant
Distinguished Professor Judith Clements and her team have identified enzymes that make ovarian cancer resistant to chemotherapy.

QUT scientists are making significant inroads into our understanding of the deadliest form of ovarian cancer after identifying two enzymes that make it resistant to chemotherapy.

Distinguished Professor Judith Clements said serous spreads rapidly throughout the abdominal area and ultimately becomes resistant to chemotherapy treatment.

"This form of cancer is incredibly aggressive, moving quickly from the ovaries to the abdominal cavity where the tumour cells aggregate or clump, become embedded in the wall of the abdomen and then grow at quite a rapid pace," she said.

"While chemotherapy will often work initially, this form of cancer has found a way of beating the current chemotherapy drugs and quite quickly becomes immune to treatment.

"So our research is tackling the cancer on two fronts to better understand how cancer cells aggregate and survive in the ascites fluid that accumulates in the abdomen and why it is resistant to chemotherapy.

"Funding from Cancer Council Queensland is assisting with this research."

Professor Clements said her team had developed 3-D models of the cancer using cancer cells to mimic and better understand how the cancer behaves while in the .

They are one of only a few groups of scientists in the world working with 3-D modelling for ovarian cancer.

"Our 3-D modelling in test tubes replicates the ' behavior and under microscopic conditions we can see how it works and our understanding of the cancer has greatly improved.

"We have also identified two enzymes that when present in a tumor make the cancer resistant to chemotherapy. We are one of two groups in the world working on these enzymes at the cellular biological level in ovarian cancer.

"This is a very significant step forward because once we know how and why ovarian cancer is resistant to chemotherapy we can then work on possible solutions."

Professor Clements said her team, located at Brisbane's Translational Research Institute (TRI) was already working with Associate Professor Jonathan Harris at QUT's Institute of Health and Biomedical Innovation (IHBI) who had developed a drug which in laboratory testing, had been found to inhibit the identified enzymes.

"This is potentially a major milestone in the road to the development of better treatment for this disease. We will continue to work with Professor Harris to develop a clinically effective version of this drug and test the drug in our lab before moving to animal and ultimately human trials," she said.

"We know that we are making incremental yet significant advances to combat this most aggressive form of cancer."

In Queensland each year, around 248 women are diagnosed with ovarian cancer and about 137 women die from the disease.

Cancer Council Queensland spokesperson Katie Clift said the ovarian cancer was often diagnosed after it had spread, reducing the chances of survival significantly.

"If ovarian cancer is treated when confined to the ovaries, 93 per cent of patients will be alive in five years," Ms Clift said.

"If the cancer spreads to surrounding tissue or organs, only 39 per cent of patients will be alive after five years. If the cancer spreads more distantly, the figure drops to just 30 per cent of patients who will survive five years after diagnosis."

Explore further: Ovarian cancer stem cells targeted in new research

Related Stories

Ovarian cancer stem cells targeted in new research

October 5, 2012
Ovarian cancer takes the lives of nearly 900 Australian women each year. It's called the silent killer because by the time most cases are detected, the cancer has spread to other vital organs throughout the abdominal area.

Drug delivery system successfully treats deadly ovarian cancer in mice

December 6, 2013
(Medical Xpress)—Scientists at Rutgers University have developed a targeted drug delivery system that they believe could make ovarian cancer more treatable and increase survival rates for the most deadly gynecological cancer ...

New drug extends life in women with advanced ovarian cancer

November 5, 2013
Women with ovarian cancer that has returned after previous treatment had their life extended by almost three months after treatment with a drug called Cediranib, according to trial results presented today at the National ...

Ovarian cancer discovery deepens knowledge of survival outcomes

December 9, 2013
Researchers in the Women's Cancer Program at Cedars-Sinai's Samuel Oschin Comprehensive Cancer Institute have identified a series of 10 genes that may signify a trifecta of benefits for women diagnosed with ovarian cancer ...

New ovarian cancer treatment succeeds in the lab

October 17, 2013
In a study to be published today in Scientific Reports, researchers from the Florida International University Herbert Wertheim College of Medicine and the FIU College of Engineering and Computing describe what could be a ...

New research shows 'DNA tags' could guide treatment for advanced ovarian cancer

October 15, 2013
A Cancer Research UK study has identified chemical 'tags' on DNA in patients' tumours that could help doctors decide the type of chemotherapy women with advanced ovarian cancer should receive, according to a new paper published ...

Recommended for you

Cancer-death button gets jammed by gut bacterium

July 27, 2017
Researchers at Michigan Medicine and in China showed that a type of bacterium is associated with the recurrence of colorectal cancer and poor outcomes. They found that Fusobacterium nucleatum in the gut can stop chemotherapy ...

Researchers release first draft of a genome-wide cancer 'dependency map'

July 27, 2017
In one of the largest efforts to build a comprehensive catalog of genetic vulnerabilities in cancer, researchers from the Broad Institute of MIT and Harvard and Dana-Farber Cancer Institute have identified more than 760 genes ...

Long-sought mechanism of metastasis is discovered in pancreatic cancer

July 27, 2017
Cells, just like people, have memories. They retain molecular markers that at the beginning of their existence helped guide their development. Cells that become cancerous may be making use of these early memories to power ...

Manmade peptides reduce breast cancer's spread

July 27, 2017
Manmade peptides that directly disrupt the inner workings of a gene known to support cancer's spread significantly reduce metastasis in a mouse model of breast cancer, scientists say.

Blocking the back-door that cancer cells use to escape death by radiotherapy

July 27, 2017
A natural healing mechanism of the body may be reducing the efficiency of radiotherapy in breast cancer patients, according to a new study.

Glowing tumor technology helps surgeons remove hidden cancer cells

July 27, 2017
Surgeons were able to identify and remove a greater number of cancerous nodules from lung cancer patients when combining intraoperative molecular imaging (IMI) - through the use of a contrast agent that makes tumor cells ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.